Molecular Med Tri-Con Main Conf. 2016

Molecular Med Tri-Con Main Conf. 2016

Molecular Med Tri-Con Main Conf. 2016

San Francisco, CA, March 6-11, 2016, Booth 632

Recent News

QuanDx/Zeesan Biotech’s MeltPro High Risk HPV Genotyping Assay is Effective for Cervical Cancer Screening for Women in Low- and Middle-Income Countries


2019-05-21

0

GenomeWeb Reports a feature story on QuanDx HPV testing by Dartmouth research group led by Dr. Tsongalis


2019-05-29

0

QuanDx Announces Distribution Agreement for the Zeesan CE-IVD High Risk HPV Genotyping Assay


2015-11-24

0

See you at AMP annual meeting in Austin, TX


2015-09-24

0

QuanDx Raises $3.0 Million in Series B2 Financing


2016-01-11

0
Cover Image for

Sitemap|Privacy Policy|Terms of Use

© QuanDx. All Rights reserved.

Contact Us

Toll Free in US
1-855-782-6392
1-855-QuanDx-Care

Info@Quandx.Com

Stay Connected